Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

255 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Comparison of HiDAC Versus FLAG-IDA in the Treatment of Relapsed Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome.
Tang MW, Van der Tuin D, Aydin M, Heijmans J, Van de Loosdrecht AA, Meijer E, Rutten CE, Wondergem M, Janssen JJWM, Donker ML, Hazenberg MD, Zweegman S, Biemond BJ, De Leeuw DC, Nur E. Tang MW, et al. Among authors: van de loosdrecht aa. Eur J Haematol. 2024 Dec 26. doi: 10.1111/ejh.14370. Online ahead of print. Eur J Haematol. 2024. PMID: 39726233
Molecular characterization of mutant TP53 acute myeloid leukemia and high-risk myelodysplastic syndrome.
Grob T, Al Hinai ASA, Sanders MA, Kavelaars FG, Rijken M, Gradowska PL, Biemond BJ, Breems DA, Maertens J, van Marwijk Kooy M, Pabst T, de Weerdt O, Ossenkoppele GJ, van de Loosdrecht AA, Huls GA, Cornelissen JJ, Beverloo HB, Löwenberg B, Jongen-Lavrencic M, Valk PJM. Grob T, et al. Among authors: van marwijk kooy m, de weerdt o, van de loosdrecht aa. Blood. 2022 Apr 14;139(15):2347-2354. doi: 10.1182/blood.2021014472. Blood. 2022. PMID: 35108372 Free PMC article.
Impact of hemodilution on flow cytometry based measurable residual disease assessment in acute myeloid leukemia.
Tettero JM, Heidinga ME, Mocking TR, Fransen G, Kelder A, Scholten WJ, Snel AN, Ngai LL, Bachas C, van de Loosdrecht AA, Ossenkoppele GJ, de Leeuw DC, Cloos J, Janssen JJWM. Tettero JM, et al. Among authors: de leeuw dc, van de loosdrecht aa. Leukemia. 2024 Mar;38(3):630-639. doi: 10.1038/s41375-024-02158-1. Epub 2024 Jan 25. Leukemia. 2024. PMID: 38272991 Free PMC article.
A threshold of 10% for myeloperoxidase by flow cytometry is valid to classify acute leukemia of ambiguous and myeloid origin.
van den Ancker W, Westers TM, de Leeuw DC, van der Veeken YF, Loonen A, van Beckhoven E, Ossenkoppele GJ, van de Loosdrecht AA. van den Ancker W, et al. Among authors: de leeuw dc, van beckhoven e, van de loosdrecht aa, van der veeken yf. Cytometry B Clin Cytom. 2013 Mar;84(2):114-8. doi: 10.1002/cyto.b.21072. Epub 2013 Jan 16. Cytometry B Clin Cytom. 2013. PMID: 23325578 Free article.
MicroRNA profiling can classify acute leukemias of ambiguous lineage as either acute myeloid leukemia or acute lymphoid leukemia.
de Leeuw DC, van den Ancker W, Denkers F, de Menezes RX, Westers TM, Ossenkoppele GJ, van de Loosdrecht AA, Smit L. de Leeuw DC, et al. Among authors: van den ancker w, de menezes rx, van de loosdrecht aa. Clin Cancer Res. 2013 Apr 15;19(8):2187-96. doi: 10.1158/1078-0432.CCR-12-3657. Epub 2013 Feb 26. Clin Cancer Res. 2013. PMID: 23444217
Challenging diagnosis in a patient with clear lymphoid immunohistochemical features and myeloid morphology: mixed phenotype acute leukemia with erythrophagocytosis.
de Leeuw DC, van den Ancker W, Westers TM, Loonen AH, Bhola SL, Ossenkoppele GJ, van de Loosdrecht AA. de Leeuw DC, et al. Among authors: van den ancker w, van de loosdrecht aa. Leuk Res. 2011 May;35(5):693-6. doi: 10.1016/j.leukres.2011.01.024. Epub 2011 Feb 21. Leuk Res. 2011. PMID: 21334744 No abstract available.
Platelet doubling after the first azacitidine cycle is a promising predictor for response in myelodysplastic syndromes (MDS), chronic myelomonocytic leukaemia (CMML) and acute myeloid leukaemia (AML) patients in the Dutch azacitidine compassionate named patient programme.
van der Helm LH, Alhan C, Wijermans PW, van Marwijk Kooy M, Schaafsma R, Biemond BJ, Beeker A, Hoogendoorn M, van Rees BP, de Weerdt O, Wegman J, Libourel WJ, Luykx-de Bakker SA, Minnema MC, Brouwer RE, Croon-de Boer F, Eefting M, Jie KS, van de Loosdrecht AA, Koedam J, Veeger NJ, Vellenga E, Huls G. van der Helm LH, et al. Among authors: van marwijk kooy m, de weerdt o, van de loosdrecht aa, van rees bp. Br J Haematol. 2011 Dec;155(5):599-606. doi: 10.1111/j.1365-2141.2011.08893.x. Epub 2011 Oct 8. Br J Haematol. 2011. PMID: 21981697 Free article. Clinical Trial.
255 results